Cargando…
CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer
Breast cancer (BC) is the most common type of cancer in women at the global level and the highest mortality rate has been observed with triple-negative breast cancer (TNBC). Accumulation of genetic lesions an aberrant gene expression and protein degradation are considered to underlie the onset of tu...
Autores principales: | Deepak Singh, Desh, Han, Ihn, Choi, Eun-Ha, Yadav, Dharmendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120801/ https://www.ncbi.nlm.nih.gov/pubmed/34025931 http://dx.doi.org/10.1016/j.csbj.2021.04.036 |
Ejemplares similares
-
Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer
por: Singh, Desh Deepak, et al.
Publicado: (2023) -
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020) -
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020) -
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
por: Singh, Desh Deepak, et al.
Publicado: (2023) -
Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Yadav, Dharmendra Kumar, et al.
Publicado: (2021)